Algorics Inc., one of the fastest-growing biometrics and data science companies, expands its board of directors with another key appointment.
The newest member to join the board, Mr. Amit M Patel comes with twenty-five years of healthcare industry experience with publicly traded, private-equity-backed, and start-up companies in various capacities including C-suite, board member, advisor, and investor. Amit has expertise across biopharma, pharma services, and other healthcare segments, and is currently a board member at multiple private-equity-backed portfolio companies.
“I welcome the opportunity to be involved with Algorics as a board member during this high-growth phase of the company, and supporting its mission of accelerating data-centric drug development,” said Amit upon his appointment.
In his prior executive roles with Azurity Pharmaceuticals, Capsugel, and Dr. Reddy’s Laboratories, Amit has led businesses with over $1B in gross revenue and 1000 employees, and a global presence across the Americas, Europe, and Asia.
“We are glad to have Amit on board and believe his industry insights will be key as we enter the next phase of growth at Algorics,” said Nithiya Ananthakrishnan, CEO of Algorics. “With our diverse client base across large biopharma, emerging biotechs, CROs, and medical devices companies, Amit’s expertise will help us drive increasing value for our customers.”
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!